Nagar SP, Fan Y, Meyers J, Tighe RM. Real-world treatment patterns of nintedanib among patients with idiopathic pulmonary fibrosis in the United States. Poster presented at the 2018 AMCP NEXUS; October 24, 2018. Orlando, FL. [abstract] J Manag Care Pharm. 2018 Oct; 24(10-a):S71.
Dhamane A, Candrilli S, Meyers J, Luthra R, Kaila S. Initial diagnosis and treatment patterns by healthcare setting among chronic obstructive pulmonary disease (COPD) patients in the United States. Poster presented at the 2016 AMCP Managed Care & Specialty Pharmacy Annual Meeting; April 2016. San Francisco, CA. [abstract] J Manag Care Pharm. 2016 Apr; 22(4-a):S90.
Stanford RH, Nagar S, Lin X, O'Connor RD. Use of ICS/LABA on asthma exacerbation risk in patients within a medical group. J Manag Care Pharm. 2015 Nov;21(11):1014-9.
Hogue S, Hollis K, Silvia S, Wooddell M, White MV. Staff training and use of epinephrine auto-injectors for the treatment of anaphylaxis: results from the EPIPEN4SCHOOLS survey. Poster presented at the 2015 AMCP Nexus; October 27, 2015. Orlando, FL. [abstract] J Manag Care Pharm. 2015 Oct; 21(10a):s7.
Dalal AA, Patel JP, D'Souza A, Farrelly E, Nagar S, Shah M. Impact of COPD exacerbation frequency on costs for a managed care population. J Manag Care Pharm. 2015 Jul;21(7):575-83.
Patel J, Coleman A, Wilson M, McDade C, Carr S, Earnshaw S. Budgetary impact on a U.S. health plan after adopting umeclidinium/vilanterol (UMEC/VI) for the management of moderate-to-severe COPD. Poster presented at the 2015 AMCP Managed Care & Specialty Pharmacy Annual Meeting; April 7, 2015. San Diego, CA. [abstract] J Manag Care Pharm. 2015 Apr 7; 21(4a):S55.